United Arab Emirates: Abu Dhabi Global Market publishes Healthcare Regulations

Onshore healthcare legislation also applies to ADGM entities.

In brief

On 11 January 2023, the Abu Dhabi Global Market (ADGM) published on its website the news about the issuance of the ADGM Healthcare Regulations 2022 ("Healthcare Regulations"). The Healthcare Regulations adopt the Abu Dhabi onshore healthcare legislation - including the regulations and circulars issued by the Department of Health Abu Dhabi (DoH) - into ADGM's legislative framework.


Contents

Key takeaways

  • The Healthcare Regulations extend the scope of the onshore health sector legislation applicable in the Emirate of Abu Dhabi to all ADGM Licensed Entities (i.e., entities licensed to operate in the ADGM).
  • Only entities with a license are allowed to practice any activity in the health sector "in or from" the ADGM.
  • The procedure to obtain a license will involve the ADGM Registration Authority at an early stage, then the DoH will be engaged to provide a technical "pre-approval", and then the matter will be passed back to the ADGM Registrar to finalize the process of the application and grant the commercial license.
  • Once the ADGM Registrar grants the license, companies will need to obtain a final license from the DoH.
  • The DoH now has the authority to monitor, inspect and review the compliance of licensed entities with the applicable health sector regulations.
  • The ADGM Registration Authority and the DoH are now authorized to set, apply and collect the respective fees payable based on the activities the applicant performs during the license application process.

In more detail

The Healthcare Regulations introduce a framework to extend onshore health sector legislation to ADGM-licensed entities, as well as healthcare professionals. It also provides guidance to address potential conflicts or inconsistencies between the onshore and offshore legal requirements.

The Healthcare Regulations clarify that no health-related activities are permitted to be performed in or from the ADGM unless conducted by a Health Facility or a Health Professional (both terms, as defined in the Healthcare Regulations) who is licensed to practice in the ADGM also by the DoH.

According to the Healthcare Regulations, in order to conduct a regulated health-related activity from the ADGM, an entity must secure: (i) a commercial license from the ADGM Registration Authority; and (ii) a valid license from the DoH. Applicants should also pay administrative fees to both the ADGM Registration Authority, and the DoH for the activities carried out during the application process.

The Healthcare Regulations establish a procedure to obtain a commercial license to practice health-related activities in the ADGM, which is as follows:

  1. Initially, an assessment of the application will be conducted by the ADGM Registration Authority.
  2. If the ADGM Registration Authority decides to proceed with the application, it will refer it to the DoH to seek their technical "pre-approval".
  3. After the DoH provides its pre-approval, the ADGM Registrar will finalize the process of the application and grant a commercial license.
  4. Following this, applicants will be referred to the DoH in order to obtain a final license.

The Healthcare Regulations also introduce new rights for the DoH to monitor, inspect and review licensed entities' compliance with the standards, requirements, conditions and procedures it imposes.

This development can be welcomed on the basis that it creates a more uniform legal framework in the health sector throughout the Emirate of Abu Dhabi as well as provides more clarity for licensed entities on the legal requirements applicable to their activities. This development will, in practice, indirectly impact providers of health tech services - which will be required to comply with the Abu Dhabi Standard for Health Information Security and Cyber Security Standards ("Standards") according to Circular No. 147 of 2022 recently issued by the DoH ("Circular"). For more information on the impact of the Circular, please see our previous alert here.

Notably, the Circular states that licensed entities must apply stricter cybersecurity controls, including ensuring health data are not transmitted outside of the UAE and discontinuing the use of any cloud-based services that store or utilize health data, irrespective of whether that solution is hosted within or outside the UAE. These restrictions will, in practice, override the more permissive regime for transferring sensitive personal data under the ADGM Data Protection Regulations 2021.

To speak to us in relation to any health data matters or broader data and technology issues, please reach out to the Baker McKenzie contacts above.

For future updates, you can visit and subscribe to our Middle East Insights blog here.

 

© 2023 Habib Al Mulla & Partners, a member firm of Baker & McKenzie International. All rights reserved. Habib Al Mulla & Partners, a member firm of Baker & McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a "partner" means a person who is a partner, or equivalent, in such a law firm. Similarly, reference to an "office" means an office of any such law firm. This may qualify as “Attorney Advertising” requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.


Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.